Abstract:Background Invasive fungal infection (IFI) is a common and fatal complication in neutropenic patients with hematological malignancy. Empirical antifungal therapy is widely used in practice due to the difficulty of pathogens determination and illness of the hosts. The aim of this study was to evaluate the efficacy and safety of itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematologic malignancies.Methods Two hundred and seventy-four patients with hematologic malignancies who had suspected fungal infections were enrolled in 18 centers across China between April 2008 and April 2009. Empirical antifungal therapy with intravenous itraconazole 200 mg twice daily was given for the first two days, followed by 200 mg once daily for the next 12 days. Oral itraconazole solution was sequential for follow-up therapy if necessary. Five composite end points were evaluated for the response, which was more restrictive and adopted for the first time in such study in China.Results The intent-to-treat analysis included data from 274 patients (full analysis set, FAS), of whom 248 were included as the per-protocol population (PPS). As the composite end point of five indices was concerned, the overall response rate was 43.4%. Seperately, defervescence was achieved in 90% of patients in which 55.5% occured during neutropenia. The mean time to defervescence was 2.71 days. Absence of breakthrough IFI during drug administration or within the first 7 days after study completion was observed in 71.5% of patients. Fifty-five point five percent patients with IFI at baseline was successfully treated. Ninety point five percent patients survived for at least 7 days after completing the study. PPS analysis revealed that the duration of neutropenia >= 10 days was a statistically significant negative predictor for the response. The withdrawal rate due to drug-related toxicity or lack of efficacy was 11.0%. The incidence of adverse events was 22.6%, in which 11.6% was study drug related. The most frequent adverse events were mild to moderate liver toxicity.Conclusion ltraconazole shows desirable efficacy and safety as empirical antifungal therapy for febrile neutropenic patients with hematologic malignancies. Chin Med J 2011;124(22):3670-3675

Successfully treatment of chromoblastomycosis with itraconazole and terbinafine association:a case report

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

Treatment of chromoblastomycosis with itraconazole and full-thickness grafts

Successful Treatment of Chromoblastomycosis of 10-Year Duration Due to Fonsecaea Nubica

Successful treatment for chromoblastomycosis caused by <i>Fonsecaea monophora</i>: a report of three cases in Guangdong, China

Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.

A Refractory Case of Chromoblastomycosis Due to Fonsecaea Monophora with Improvement by Photodynamic Therapy.

Chromoblastomycosis caused by Fonsecaea monophora in North China:first case report and laboratory study

Efficacy and Safety of Itraconazole on Invasive Fungal Infections in 66 Patients with Malignant Hematological Diseases

Fluconazole and fire needle therapy to treat chromoblastomycosis: a case report and literature review

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient

Efficacy and Safety of Itraconazole As Empirical Antifungal Therapy in Febrile Neutropenic Patients with Hematologic Malignancies: an Open-Lable, Multicenter, Observational Trial in A Chinese Cohort

Facial Subcutaneous Phaeohyphomycosis Caused by Phialophora Verrucosa: Successful Treatment with Itraconazole and Local Resection

Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study

A case of refractory onychomycosis caused by Kloeckera apiculata: Successful treatment with itraconazole

In Vitro Interaction of Terbinafine with Itraconazole and Amphotericin B Against Fungi Causing Chromoblastomycosis in China.

Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy

A case of subcutaneous phaeohyphomycosis manifested as cystic acne caused by Cladosporium cladosporioides

Treatment of pulmonary infection with Penicillium marneffei involved by clinical pharmacist:1 case report

The Combination Treatment of Itraconazole, Fiuconazole and Terbinafine for One Case of Pulmonary Cryptococcosis

A case of chromoblastomycosis with lymphatic spread